Meet our doctors Last reviewed: 19 Jun 2026 Sources Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Transdermal drug delivery: overcoming the skin's barrier function, Europe PMC [accessed 14 January 2026] (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteins, Advanced Drug Delivery Reviews, [accessed 14 January 2026] Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, [accessed 14 January 2026]
Retatrutide versus semaglutide comparisons show that this triple agonist may provide even better results than tirzepatide for some people, though it remains in clinical development
(*stratum corneum) Barrier Fill Complex: Helps to rapidly replenish moisture and strengthens the skins barrier
10.1136/bmj.m4573 38 PiotrowskiK.BeckerM.ZugwurstJ.Biller-FriedmannI.SpoettlG.GreifM.et al (2013)